209 related articles for article (PubMed ID: 1466001)
1. Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation.
Aomatsu Y; Iwata H; Takagi T; Amemiya H; Nakajima Y; Kanehiro H; Hisanaga M; Fukuoka T; Nakano H
Transplant Proc; 1992 Dec; 24(6):2922-3. PubMed ID: 1466001
[No Abstract] [Full Text] [Related]
2. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation.
Aomatsu Y; Nakajima Y; Iwata H; Amemiya H; Kanehiro H; Hisanaga M; Yoshimura A; Kido K; Taki J; Horikawa M
Transplant Proc; 1995 Feb; 27(1):292-3. PubMed ID: 7879008
[No Abstract] [Full Text] [Related]
3. Pancreatic islet transplantation using membrane diffusion chambers.
Lanza RP; Borland KM; Lodge P; Carretta M; Sullivan SJ; Muller TE; Solomon BA; Maki T; Monaco AP; Chick WL
Transplant Proc; 1992 Dec; 24(6):2935-6. PubMed ID: 1466004
[No Abstract] [Full Text] [Related]
4. Indefinite graft survival of discordant islet xenografts in the NOD mouse with agarose microencapsulation and 15-deoxyspergualin.
Aomatsu Y; Nakajima Y; Iwata H; Takagi T; Amemiya H; Kanehiro H; Hisanaga M; Fukuoka T; Yoshimura A; Kido K
Transplant Proc; 1994 Apr; 26(2):805-6. PubMed ID: 8171669
[No Abstract] [Full Text] [Related]
5. 15-Deoxyspergualin attenuates pericapsular cellular infiltration and prolongs survival of alginate-poly-L-lysine-alginate microencapsulated islets.
Hsu BR; Fu SH; Hsueh C; Tsai JS; Huang YY; Huang HS
Transplant Proc; 1997 Jun; 29(4):2158-60. PubMed ID: 9193570
[No Abstract] [Full Text] [Related]
6. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
Henretta J; Pittman K; McFadden T; Thomas F
Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
[No Abstract] [Full Text] [Related]
7. Immunoisolative effectiveness and limitation of agarose in a bioartificial pancreas.
Iwata H; Takagi T; Kobayashi K; Yang H; Ito F
Transplant Proc; 1994 Apr; 26(2):789. PubMed ID: 8171663
[No Abstract] [Full Text] [Related]
8. Induction of functional xenograft tolerance of pig islets in the autoimmune NOD mouse.
Thomas FT; Pittman K; Thomas JM
Transplant Proc; 1995 Dec; 27(6):3323-5. PubMed ID: 8539973
[No Abstract] [Full Text] [Related]
9. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
Wright JR; Kearns H
Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
[No Abstract] [Full Text] [Related]
10. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
[TBL] [Abstract][Full Text] [Related]
11. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
Transplant Proc; 1992 Jun; 24(3):997. PubMed ID: 1604705
[No Abstract] [Full Text] [Related]
12. Effect of 15-deoxyspergualin in islet xenograft rejection.
Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
[No Abstract] [Full Text] [Related]
13. Successful rat-to-mouse xenotransplantation of Langerhans islets microencapsulated within a protamine-heparin membrane.
Tatarkiewicz K; Sitarek E; Fiedor P; Sabat M; Morzycka-Michalik M; Orlowski T
Transplant Proc; 1994 Apr; 26(2):807-8. PubMed ID: 8171670
[No Abstract] [Full Text] [Related]
14. Effect of mycophenolate mofetil on islet allografting to chemically induced or spontaneously diabetic animals.
Hao L; Wang Y; Chan SM; Lafferty KJ
Transplant Proc; 1992 Dec; 24(6):2843-4. PubMed ID: 1465967
[No Abstract] [Full Text] [Related]
15. Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanga M; Ko S; Nagao M; Harb G; Nakajima Y
Cell Transplant; 2006; 15(4):359-65. PubMed ID: 16898230
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of agarose/polystyrene sulfonic acid microencapsulation for islet xenotransplantation.
Aomatsu Y; Nakajima Y; Ohyama T; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Tatekawa Y; Sho M; Ikeda N; Kanokogi H; Kobayashi T; Urizono Y; Yamada T; Shibaji T; Kanamura T; Ogawa S; Iwata H; Nakano H
Transplant Proc; 2000 Aug; 32(5):1071-2. PubMed ID: 10936363
[No Abstract] [Full Text] [Related]
18. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
[No Abstract] [Full Text] [Related]
19. Agarose microcapsule applied in islet xenografts (hamster to mouse).
Iwata H; Takagi T; Amemiya H
Transplant Proc; 1992 Jun; 24(3):952. PubMed ID: 1604680
[No Abstract] [Full Text] [Related]
20. Agarose for a bioartificial pancreas.
Iwata H; Takagi T; Amemiya H; Shimizu H; Yamashita K; Kobayashi K; Akutsu T
J Biomed Mater Res; 1992 Jul; 26(7):967-77. PubMed ID: 1607377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
